Skip to search boxSkip to navigationSkip to main content

Hepatitis viruses and the MAPK pathway: Is this a survival strategy?

  • Milena Panteva
    ,
  • Hasan Korkaya
    ,
  • Shahid Jameel
  • International Centre for Genetic Engineering and Biotechnology
Scholary Output:
Contribution to journal
Review article
Research
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>The viruses that cause hepatitis comprise of at least five different agents, which share the ability to cause inflammation and necrosis of the liver. The disease spectrum is quite diverse and the outcome of infection by the different hepatitis viruses can be rationalized based on virus-host cell interactions. New insights into the molecular basis of viral hepatitis reveal that three of these agents - the hepatitis B, C and E viruses (HBV, HCV and HEV) modulate the mitogen-activated protein kinase (MAPK) signaling pathway. In this review we briefly describe the structural organization of the MAPK cascade and emphasize its importance as a central pathway in the signaling network. Selected mechanisms through which HBV, HCV and HEV proteins target various steps in the MAPK pathway are discussed and used to propose a pro-survival outcome for the host cell. In addition, we offer an insight into how the common theme of MAPK activation and its downstream effects may be used to rationalize the different outcomes of hepatitis B, C and E.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 131-140 (10 pages)

Journal (Volume, Issue Number)

Virus Research (Volume 92, Issue 2)

Publication milestones

  • Published - 04/01/2003

Publication status

Published - 04/01/2003

ISSN

0168-1702

Publication IDs

  • Scopus: 0037383040
  • PubMed: 12686421

Publication metrics

Metrics

SciVal
FWCI
0.52
SciVal
Author count
3
SciVal
citations
56
SciVal
Paper percentile
87
Scopus
citations
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Mentions
1
Citation count
81
Captures
45

Funding Details

Work in the authors’ laboratory is supported by internal funds from the ICGEB and through an International Senior Research Fellowship in Biomedical Sciences of the Wellcome Trust. M.P. extends sincere gratitude to Assoc. Prof. T. Varadinova for the encouragement and support during the early stages of her career.
FundersFunding numbers
WT
-
ICGEB
-